EcoDrugPlus

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSODEG00000007884
Gene Symbol: FLT3
1 Cross references
133 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSODEG00000006420
Gene Symbol: FLT4
1 Cross references
195 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSODEG00000000420
Gene Symbol: FOLH1
1 Cross references
210 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSODEG00000006777
Gene Symbol: FOLR1
3 Cross references
217 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSODEG00000014615
Gene Symbol: FSHR
3 Cross references
199 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSODEG00000020315
Gene Symbol: FFAR1
3 Cross references
138 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSODEG00000020307
Gene Symbol: FFAR2
3 Cross references
331 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSODEG00000000004
Gene Symbol: FRK
3 Cross references
216 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSODEG00000002672
Gene Symbol: GLA
3 Cross references
196 Possible Orthologues:

Galectin 1

Ensembl ID : ENSODEG00000011480
Gene Symbol: LGALS1
1 Cross references
380 Possible Orthologues:

Galectin-3-Like

Ensembl ID : ENSODEG00000020146
Gene Symbol: LOC101565149
2 Cross references
217 Possible Orthologues:

Galectin-3-Like

Ensembl ID : ENSODEG00000008942
Gene Symbol: LOC101585489
2 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).